SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-033637
Filing Date
2023-12-05
Accepted
2023-12-05 16:05:45
Documents
13
Period of Report
2023-12-05
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20231204c_8k.htm   iXBRL 8-K 25780
  Complete submission text file 0001437749-23-033637.txt   172712

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcda-20231205.xsd EX-101.SCH 3873
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20231205_def.xml EX-101.DEF 13416
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20231205_lab.xml EX-101.LAB 17616
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20231205_pre.xml EX-101.PRE 13393
7 EXTRACTED XBRL INSTANCE DOCUMENT bcda20231204c_8k_htm.xml XML 4325
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231466570
SIC: 2836 Biological Products, (No Diagnostic Substances)